Get started
Author

Yu Gao

ORCID: 0000-0002-7458-2686
Observed ORCID: 0000-0002-7458-2686
OpenAlex ID: A5101769603
Heparinized PLLA/PLCL nanofibrous scaffold for potential engineering of small‐diameter blood vessel: Tunable elasticity and anticoagulation property
2014 · Weizhong Wang, Jinwei Hu, et al. · Journal of Biomedical Materials Research Part A · 68
Antitumor efficacy of a PLGA composite nanofiber embedded with doxorubicin@MSNs and hydroxycamptothecin@HANPs
2014 · Mengxia Chen, Wei Feng, et al. · RSC Advances · 49
Biodegradable Alginate-Chitosan Hollow Nanospheres for Codelivery of Doxorubicin and Paclitaxel for the Effect of Human Lung Cancer A549 Cells
2018 · Liu Tao, Jie Jiang, et al. · BioMed Research International · 37
PDF
Targeted Delivery of Paclitaxel in Liver Cancer Using Hyaluronic Acid Functionalized Mesoporous Hollow Alumina Nanoparticles
2019 · Yu Gao, Lili Hu, et al. · BioMed Research International · 30
PDF
Preparation of Biomimetic Selenium–Baicalein Nanoparticles and Their Targeted Therapeutic Application in Nonsmall Cell Lung Cancer
2024 · Huan Shi, Biaobiao Wang, et al. · Molecular Pharmaceutics · 12
Preparation of paclitaxel-folic acid functionalized gelatin grafted mesoporous hollow carbon nanospheres for enhancing antitumor effects toward liver cancer (SMMC-7721) cell lines
2019 · Yu Gao, Tao Liu, et al. · Journal of Biomaterials Applications · 10
Functionalized realgar nanoparticles-doped degradable mesoporous silica nanoparticles loaded with temozolomide for the targeted treatment of glioma
2025 · Zhiwei Shi, Yang Qiu, et al. · Colloids and Surfaces B Biointerfaces · 3
Corrigendum to “Paclitaxel-Ang-2-functionalized bionic mesoporous selenium nanoparticles for targeted therapy of glioma” [Pharmacol. Res. 216 (2025) 107783]
2025 · Huan Shi, Biaobiao Wang, et al. · Pharmacological Research · 1
Works count: 8
Citation count: 210
H-index: 6
I10-index: 6
Year
Topic
Type